NDC 71335-1118

Methotrexate

Methotrexate

Methotrexate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Methotrexate Sodium.

Product ID71335-1118_0b54b5c4-2466-4f85-b9a0-ad93ec4a06a1
NDC71335-1118
Product TypeHuman Prescription Drug
Proprietary NameMethotrexate
Generic NameMethotrexate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1992-05-18
Marketing CategoryANDA / ANDA
Application NumberANDA081235
Labeler NameBryant Ranch Prepack
Substance NameMETHOTREXATE SODIUM
Active Ingredient Strength3 mg/1
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 71335-1118-1

30 TABLET in 1 BOTTLE (71335-1118-1)
Marketing Start Date2021-09-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1118-8 [71335111808]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-28

NDC 71335-1118-7 [71335111807]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-28

NDC 71335-1118-1 [71335111801]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-28

NDC 71335-1118-5 [71335111805]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-28

NDC 71335-1118-4 [71335111804]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-28

NDC 71335-1118-6 [71335111806]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-28

NDC 71335-1118-3 [71335111803]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-28

NDC 71335-1118-2 [71335111802]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-28

Drug Details

Active Ingredients

IngredientStrength
METHOTREXATE SODIUM2.5 mg/1

OpenFDA Data

SPL SET ID:0b54b5c4-2466-4f85-b9a0-ad93ec4a06a1
Manufacturer
UNII

Pharmacological Class

  • Folate Analog Metabolic Inhibitor [EPC]
  • Folic Acid Metabolism Inhibitors [MoA]
  • Folate Analog Metabolic Inhibitor [EPC]
  • Folic Acid Metabolism Inhibitors [MoA]

NDC Crossover Matching brand name "Methotrexate" or generic name "Methotrexate"

NDCBrand NameGeneric Name
0143-9367MethotrexateMethotrexate
0143-9516MethotrexateMethotrexate
0143-9517MethotrexateMethotrexate
0143-9518MethotrexateMethotrexate
0143-9519MethotrexateMethotrexate
0143-9830MethotrexateMethotrexate
0378-0014Methotrexatemethotrexate
0555-0572MethotrexateMethotrexate
0703-3671MethotrexateMethotrexate
0703-3675MethotrexateMethotrexate
0703-3678MethotrexateMethotrexate
68382-775MethotrexateMethotrexate
69238-1423MethotrexateMethotrexate
70518-0223METHOTREXATEMETHOTREXATE
70518-1251MethotrexateMethotrexate
70518-1398MethotrexateMethotrexate
70771-1058MethotrexateMethotrexate
71335-0782MethotrexateMethotrexate
16729-277MethotrexateMethotrexate
21695-111MethotrexateMethotrexate
42291-594MethotrexateMethotrexate
42254-110METHOTREXATEMETHOTREXATE
43063-439MethotrexateMethotrexate
47335-235MethotrexateMethotrexate
50090-0294METHOTREXATEMETHOTREXATE
50090-2345MethotrexateMethotrexate
50090-3418MethotrexateMethotrexate
51079-670MethotrexateMethotrexate
51407-121MethotrexateMethotrexate
61703-350MethotrexateMethotrexate
61703-408MethotrexateMethotrexate
63323-122MethotrexateMethotrexate
63323-123MethotrexateMethotrexate
66336-338METHOTREXATEMETHOTREXATE
67253-320METHOTREXATEMETHOTREXATE
67457-480MethotrexateMethotrexate
67457-466MethotrexateMethotrexate
71335-1118MethotrexateMethotrexate

© 2023 FDA.report
This site is not affiliated with or endorsed by the FDA.